B:Havior IVS: Financial statements 2020
CVR: 38277022
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
B:Havior IVS (CVR 38277022) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -3,125 the year before. Equity in the 2020 report amounted to DKK 0.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 0 | 0 | 0 | - |
| 2019 | - | -3 t. | -3 t. | 16 t. | - |
| 2018 | 103 t. | 19 t. | 19 t. | 19 t. | - |
| 2017 | 0 | 0 | 0 | 1 | - |
Official annual report
How creditworthy is B:Havior IVS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
B:Havior IVS has published its annual report for 2019. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
About B:Havior IVS
B:Havior IVS was a Danish company of the type Iværksætterselskab based in Rødovre, founded in 2016. The company has been dissolved on 10 November 2021. The company was registered under the industry Sundhedsvæsen i øvrigt i.a.n.. The company was previously named SEPAS Health IVS. In 2020, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK -3,125 the year before. Equity in the 2020 report amounted to DKK 0.